phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Drug From Stony Brook-Developed Anti-Cancer Compounds Now in Clinical Trials

A promising new cancer chemotherapeutic agent from a taxane class of natural compounds - anti-cancer agents designed to block cell division and trigger the programmed cell death to treat sold tumors - originally developed by researchers at Stony Brook University has entered human clinical trials.

November 5, 2026


November 9 2026

November 8 2026

November 7 2026

November 6 2026

November 5 2026

November 4 2026

November 3 2026

November 2 2026

November 1 2026

October 30 2026

October 29 2026

October 28 2026

October 27 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy